nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—DRD2—nicotine dependence	0.524	1	CbGaD
Aripiprazole—Muscle enzyme increased—Varenicline—nicotine dependence	0.0153	0.0571	CcSEcCtD
Aripiprazole—Electrocardiogram T wave amplitude decreased—Varenicline—nicotine dependence	0.0153	0.0571	CcSEcCtD
Aripiprazole—Psychomotor skills impaired—Varenicline—nicotine dependence	0.0111	0.0413	CcSEcCtD
Aripiprazole—Costochondritis—Varenicline—nicotine dependence	0.0088	0.0328	CcSEcCtD
Aripiprazole—Homicidal ideation—Varenicline—nicotine dependence	0.00736	0.0274	CcSEcCtD
Aripiprazole—Bradyphrenia—Varenicline—nicotine dependence	0.00682	0.0254	CcSEcCtD
Aripiprazole—Chest wall pain—Varenicline—nicotine dependence	0.00505	0.0188	CcSEcCtD
Aripiprazole—Panic reaction—Varenicline—nicotine dependence	0.0046	0.0171	CcSEcCtD
Aripiprazole—Somnambulism—Varenicline—nicotine dependence	0.0046	0.0171	CcSEcCtD
Aripiprazole—Mental retardation—Varenicline—nicotine dependence	0.00423	0.0157	CcSEcCtD
Aripiprazole—Gingival pain—Varenicline—nicotine dependence	0.00423	0.0157	CcSEcCtD
Aripiprazole—Rhinitis allergic—Varenicline—nicotine dependence	0.00407	0.0151	CcSEcCtD
Aripiprazole—Abnormal faeces—Varenicline—nicotine dependence	0.00323	0.012	CcSEcCtD
Aripiprazole—Restless legs syndrome—Varenicline—nicotine dependence	0.00323	0.012	CcSEcCtD
Aripiprazole—Polydipsia—Varenicline—nicotine dependence	0.00298	0.0111	CcSEcCtD
Aripiprazole—Facial paralysis—Varenicline—nicotine dependence	0.0029	0.0108	CcSEcCtD
Aripiprazole—Vilazodone—DRD2—nicotine dependence	0.00287	0.546	CrCbGaD
Aripiprazole—Anger—Varenicline—nicotine dependence	0.00258	0.00963	CcSEcCtD
Aripiprazole—Respiratory tract congestion—Varenicline—nicotine dependence	0.00253	0.00942	CcSEcCtD
Aripiprazole—Varicose vein—Varenicline—nicotine dependence	0.00248	0.00923	CcSEcCtD
Aripiprazole—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00238	0.00887	CcSEcCtD
Aripiprazole—Haematochezia—Varenicline—nicotine dependence	0.00229	0.00854	CcSEcCtD
Aripiprazole—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00225	0.00838	CcSEcCtD
Aripiprazole—Dysphoria—Varenicline—nicotine dependence	0.00213	0.00795	CcSEcCtD
Aripiprazole—Hoarseness—Varenicline—nicotine dependence	0.0021	0.00782	CcSEcCtD
Aripiprazole—Depressed mood—Varenicline—nicotine dependence	0.00206	0.00769	CcSEcCtD
Aripiprazole—Sinus congestion—Varenicline—nicotine dependence	0.00186	0.00691	CcSEcCtD
Aripiprazole—H1F0—cardiovascular system—nicotine dependence	0.00183	0.0348	CbGeAlD
Aripiprazole—Transient ischaemic attack—Varenicline—nicotine dependence	0.00183	0.00681	CcSEcCtD
Aripiprazole—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00178	0.00663	CcSEcCtD
Aripiprazole—Suicide—Varenicline—nicotine dependence	0.00178	0.00663	CcSEcCtD
Aripiprazole—DRD4—brain—nicotine dependence	0.00176	0.0335	CbGeAlD
Aripiprazole—Night sweats—Varenicline—nicotine dependence	0.00171	0.00637	CcSEcCtD
Aripiprazole—Balance disorder—Varenicline—nicotine dependence	0.00169	0.00629	CcSEcCtD
Aripiprazole—Hostility—Varenicline—nicotine dependence	0.00167	0.00621	CcSEcCtD
Aripiprazole—Osteoporosis—Varenicline—nicotine dependence	0.00165	0.00613	CcSEcCtD
Aripiprazole—Sexual dysfunction—Varenicline—nicotine dependence	0.00165	0.00613	CcSEcCtD
Aripiprazole—Suicide attempt—Varenicline—nicotine dependence	0.00163	0.00606	CcSEcCtD
Aripiprazole—Completed suicide—Varenicline—nicotine dependence	0.00157	0.00585	CcSEcCtD
Aripiprazole—HTR1E—brain—nicotine dependence	0.00152	0.0289	CbGeAlD
Aripiprazole—Libido increased—Varenicline—nicotine dependence	0.00152	0.00565	CcSEcCtD
Aripiprazole—Vaginal discharge—Varenicline—nicotine dependence	0.00152	0.00565	CcSEcCtD
Aripiprazole—Toothache—Varenicline—nicotine dependence	0.00152	0.00565	CcSEcCtD
Aripiprazole—Psoriasis—Varenicline—nicotine dependence	0.00147	0.00547	CcSEcCtD
Aripiprazole—HTR1B—cardiovascular system—nicotine dependence	0.00146	0.0278	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—nicotine dependence	0.00146	0.0277	CbGeAlD
Aripiprazole—H1F0—midbrain—nicotine dependence	0.00143	0.0271	CbGeAlD
Aripiprazole—Parosmia—Varenicline—nicotine dependence	0.00142	0.0053	CcSEcCtD
Aripiprazole—HTR1D—cardiovascular system—nicotine dependence	0.00142	0.0269	CbGeAlD
Aripiprazole—DRD1—midbrain—nicotine dependence	0.00141	0.0268	CbGeAlD
Aripiprazole—Upset stomach—Varenicline—nicotine dependence	0.00141	0.00525	CcSEcCtD
Aripiprazole—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00141	0.00525	CcSEcCtD
Aripiprazole—Cyst—Varenicline—nicotine dependence	0.00138	0.00514	CcSEcCtD
Aripiprazole—ADRB1—cardiovascular system—nicotine dependence	0.00138	0.0262	CbGeAlD
Aripiprazole—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00137	0.00509	CcSEcCtD
Aripiprazole—Laryngeal pain—Varenicline—nicotine dependence	0.00135	0.00504	CcSEcCtD
Aripiprazole—Intestinal obstruction—Varenicline—nicotine dependence	0.00135	0.00504	CcSEcCtD
Aripiprazole—Paranoia—Varenicline—nicotine dependence	0.00135	0.00504	CcSEcCtD
Aripiprazole—CHRM4—brain—nicotine dependence	0.00133	0.0253	CbGeAlD
Aripiprazole—Haematemesis—Varenicline—nicotine dependence	0.00133	0.00495	CcSEcCtD
Aripiprazole—CHRM1—cardiovascular system—nicotine dependence	0.00133	0.0252	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—nicotine dependence	0.00132	0.025	CbGeAlD
Aripiprazole—Suicidal ideation—Varenicline—nicotine dependence	0.00132	0.0049	CcSEcCtD
Aripiprazole—Delusion—Varenicline—nicotine dependence	0.0013	0.00486	CcSEcCtD
Aripiprazole—Hyperlipidaemia—Varenicline—nicotine dependence	0.00128	0.00477	CcSEcCtD
Aripiprazole—Mania—Varenicline—nicotine dependence	0.00127	0.00473	CcSEcCtD
Aripiprazole—Menorrhagia—Varenicline—nicotine dependence	0.00125	0.00465	CcSEcCtD
Aripiprazole—DRD3—brain—nicotine dependence	0.00124	0.0235	CbGeAlD
Aripiprazole—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00123	0.00457	CcSEcCtD
Aripiprazole—HTR6—brain—nicotine dependence	0.00119	0.0226	CbGeAlD
Aripiprazole—HTR1A—cardiovascular system—nicotine dependence	0.00118	0.0224	CbGeAlD
Aripiprazole—Gingivitis—Varenicline—nicotine dependence	0.00118	0.00438	CcSEcCtD
Aripiprazole—DRD5—brain—nicotine dependence	0.00116	0.022	CbGeAlD
Aripiprazole—Nephrolithiasis—Varenicline—nicotine dependence	0.00115	0.00428	CcSEcCtD
Aripiprazole—HTR1B—midbrain—nicotine dependence	0.00114	0.0217	CbGeAlD
Aripiprazole—Rhinorrhoea—Varenicline—nicotine dependence	0.00114	0.00424	CcSEcCtD
Aripiprazole—Glycosuria—Varenicline—nicotine dependence	0.00114	0.00424	CcSEcCtD
Aripiprazole—HTR7—cardiovascular system—nicotine dependence	0.00113	0.0214	CbGeAlD
Aripiprazole—Dysphonia—Varenicline—nicotine dependence	0.00112	0.00418	CcSEcCtD
Aripiprazole—Endocrine disorder—Varenicline—nicotine dependence	0.00111	0.00415	CcSEcCtD
Aripiprazole—HTR1D—midbrain—nicotine dependence	0.00111	0.021	CbGeAlD
Aripiprazole—HTR2C—midbrain—nicotine dependence	0.0011	0.0208	CbGeAlD
Aripiprazole—ADRA1A—cardiovascular system—nicotine dependence	0.00109	0.0207	CbGeAlD
Aripiprazole—Ziprasidone—DRD2—nicotine dependence	0.00109	0.207	CrCbGaD
Aripiprazole—Eye irritation—Varenicline—nicotine dependence	0.00108	0.00403	CcSEcCtD
Aripiprazole—Disturbance in attention—Varenicline—nicotine dependence	0.00107	0.00397	CcSEcCtD
Aripiprazole—Tenderness—Varenicline—nicotine dependence	0.00106	0.00394	CcSEcCtD
Aripiprazole—KCNH2—cardiovascular system—nicotine dependence	0.00105	0.02	CbGeAlD
Aripiprazole—Aggression—Varenicline—nicotine dependence	0.00105	0.00391	CcSEcCtD
Aripiprazole—Accidental injury—Varenicline—nicotine dependence	0.00104	0.00389	CcSEcCtD
Aripiprazole—Chest discomfort—Varenicline—nicotine dependence	0.00104	0.00389	CcSEcCtD
Aripiprazole—CHRM5—brain—nicotine dependence	0.00104	0.0198	CbGeAlD
Aripiprazole—SLC6A4—midbrain—nicotine dependence	0.00104	0.0197	CbGeAlD
Aripiprazole—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00102	0.00381	CcSEcCtD
Aripiprazole—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00102	0.00381	CcSEcCtD
Aripiprazole—Thinking abnormal—Varenicline—nicotine dependence	0.00101	0.00376	CcSEcCtD
Aripiprazole—Lacrimation increased—Varenicline—nicotine dependence	0.001	0.00373	CcSEcCtD
Aripiprazole—Nocturia—Varenicline—nicotine dependence	0.000995	0.00371	CcSEcCtD
Aripiprazole—Leukocytosis—Varenicline—nicotine dependence	0.000982	0.00366	CcSEcCtD
Aripiprazole—Dysarthria—Varenicline—nicotine dependence	0.000976	0.00364	CcSEcCtD
Aripiprazole—ADRA1B—brain—nicotine dependence	0.000952	0.0181	CbGeAlD
Aripiprazole—Coordination abnormal—Varenicline—nicotine dependence	0.00094	0.0035	CcSEcCtD
Aripiprazole—Musculoskeletal pain—Varenicline—nicotine dependence	0.000934	0.00348	CcSEcCtD
Aripiprazole—HTR1A—midbrain—nicotine dependence	0.000923	0.0175	CbGeAlD
Aripiprazole—Blood pressure increased—Varenicline—nicotine dependence	0.000923	0.00344	CcSEcCtD
Aripiprazole—Pulmonary embolism—Varenicline—nicotine dependence	0.000923	0.00344	CcSEcCtD
Aripiprazole—Abnormal dreams—Varenicline—nicotine dependence	0.000912	0.0034	CcSEcCtD
Aripiprazole—Eructation—Varenicline—nicotine dependence	0.000907	0.00338	CcSEcCtD
Aripiprazole—Hyperkalaemia—Varenicline—nicotine dependence	0.000907	0.00338	CcSEcCtD
Aripiprazole—H1F0—brain—nicotine dependence	0.000898	0.0171	CbGeAlD
Aripiprazole—Influenza like illness—Varenicline—nicotine dependence	0.000896	0.00334	CcSEcCtD
Aripiprazole—Salivary hypersecretion—Varenicline—nicotine dependence	0.000896	0.00334	CcSEcCtD
Aripiprazole—Nightmare—Varenicline—nicotine dependence	0.000891	0.00332	CcSEcCtD
Aripiprazole—DRD1—brain—nicotine dependence	0.000887	0.0168	CbGeAlD
Aripiprazole—HTR7—midbrain—nicotine dependence	0.000882	0.0167	CbGeAlD
Aripiprazole—Photophobia—Varenicline—nicotine dependence	0.000867	0.00323	CcSEcCtD
Aripiprazole—HTR3A—brain—nicotine dependence	0.000857	0.0163	CbGeAlD
Aripiprazole—Dry eye—Varenicline—nicotine dependence	0.000853	0.00318	CcSEcCtD
Aripiprazole—Oesophagitis—Varenicline—nicotine dependence	0.000843	0.00314	CcSEcCtD
Aripiprazole—Mouth ulceration—Varenicline—nicotine dependence	0.000835	0.00311	CcSEcCtD
Aripiprazole—Urine output increased—Varenicline—nicotine dependence	0.000835	0.00311	CcSEcCtD
Aripiprazole—DRD2—midbrain—nicotine dependence	0.000834	0.0158	CbGeAlD
Aripiprazole—KCNH2—midbrain—nicotine dependence	0.000822	0.0156	CbGeAlD
Aripiprazole—ADRA2C—midbrain—nicotine dependence	0.000811	0.0154	CbGeAlD
Aripiprazole—Hypertonia—Varenicline—nicotine dependence	0.000809	0.00301	CcSEcCtD
Aripiprazole—Mental disability—Varenicline—nicotine dependence	0.000801	0.00298	CcSEcCtD
Aripiprazole—Euphoric mood—Varenicline—nicotine dependence	0.000793	0.00295	CcSEcCtD
Aripiprazole—Lymphadenopathy—Varenicline—nicotine dependence	0.000785	0.00293	CcSEcCtD
Aripiprazole—Sleep disorder—Varenicline—nicotine dependence	0.000774	0.00288	CcSEcCtD
Aripiprazole—Diabetes mellitus—Varenicline—nicotine dependence	0.00077	0.00287	CcSEcCtD
Aripiprazole—Polyuria—Varenicline—nicotine dependence	0.000763	0.00284	CcSEcCtD
Aripiprazole—Prochlorperazine—DRD2—nicotine dependence	0.000757	0.144	CrCbGaD
Aripiprazole—Disorientation—Varenicline—nicotine dependence	0.000749	0.00279	CcSEcCtD
Aripiprazole—Deafness—Varenicline—nicotine dependence	0.000749	0.00279	CcSEcCtD
Aripiprazole—Eczema—Varenicline—nicotine dependence	0.000746	0.00278	CcSEcCtD
Aripiprazole—Eye pain—Varenicline—nicotine dependence	0.000742	0.00276	CcSEcCtD
Aripiprazole—Injury—Varenicline—nicotine dependence	0.000729	0.00272	CcSEcCtD
Aripiprazole—Libido decreased—Varenicline—nicotine dependence	0.000723	0.00269	CcSEcCtD
Aripiprazole—HTR1B—brain—nicotine dependence	0.000719	0.0136	CbGeAlD
Aripiprazole—Hot flush—Varenicline—nicotine dependence	0.000716	0.00267	CcSEcCtD
Aripiprazole—CHRM2—brain—nicotine dependence	0.000715	0.0136	CbGeAlD
Aripiprazole—Increased appetite—Varenicline—nicotine dependence	0.000713	0.00266	CcSEcCtD
Aripiprazole—Amnesia—Varenicline—nicotine dependence	0.000713	0.00266	CcSEcCtD
Aripiprazole—Menopausal symptoms—Varenicline—nicotine dependence	0.00071	0.00265	CcSEcCtD
Aripiprazole—Atrial fibrillation—Varenicline—nicotine dependence	0.000707	0.00263	CcSEcCtD
Aripiprazole—Visual disturbance—Varenicline—nicotine dependence	0.000707	0.00263	CcSEcCtD
Aripiprazole—HTR2A—cardiovascular system—nicotine dependence	0.000704	0.0134	CbGeAlD
Aripiprazole—Thirst—Varenicline—nicotine dependence	0.000704	0.00262	CcSEcCtD
Aripiprazole—HTR1D—brain—nicotine dependence	0.000696	0.0132	CbGeAlD
Aripiprazole—Arthritis—Varenicline—nicotine dependence	0.000689	0.00257	CcSEcCtD
Aripiprazole—HTR2C—brain—nicotine dependence	0.000689	0.0131	CbGeAlD
Aripiprazole—Hypoglycaemia—Varenicline—nicotine dependence	0.000687	0.00256	CcSEcCtD
Aripiprazole—Lethargy—Varenicline—nicotine dependence	0.000684	0.00255	CcSEcCtD
Aripiprazole—Cerebrovascular accident—Varenicline—nicotine dependence	0.000684	0.00255	CcSEcCtD
Aripiprazole—ADRB1—brain—nicotine dependence	0.000676	0.0128	CbGeAlD
Aripiprazole—Osteoarthritis—Varenicline—nicotine dependence	0.00067	0.0025	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00067	0.0025	CcSEcCtD
Aripiprazole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000665	0.00248	CcSEcCtD
Aripiprazole—Migraine—Varenicline—nicotine dependence	0.000659	0.00246	CcSEcCtD
Aripiprazole—Affect lability—Varenicline—nicotine dependence	0.000659	0.00246	CcSEcCtD
Aripiprazole—Psychotic disorder—Varenicline—nicotine dependence	0.000654	0.00244	CcSEcCtD
Aripiprazole—SLC6A4—brain—nicotine dependence	0.000653	0.0124	CbGeAlD
Aripiprazole—CHRM1—brain—nicotine dependence	0.000651	0.0124	CbGeAlD
Aripiprazole—HTR2B—brain—nicotine dependence	0.000647	0.0123	CbGeAlD
Aripiprazole—ADRA2A—midbrain—nicotine dependence	0.000647	0.0123	CbGeAlD
Aripiprazole—Irritability—Varenicline—nicotine dependence	0.000639	0.00238	CcSEcCtD
Aripiprazole—Urinary retention—Varenicline—nicotine dependence	0.000637	0.00237	CcSEcCtD
Aripiprazole—Mood swings—Varenicline—nicotine dependence	0.000635	0.00236	CcSEcCtD
Aripiprazole—Liver function test abnormal—Varenicline—nicotine dependence	0.000619	0.0023	CcSEcCtD
Aripiprazole—Dry skin—Varenicline—nicotine dependence	0.000614	0.00229	CcSEcCtD
Aripiprazole—Abdominal pain upper—Varenicline—nicotine dependence	0.000612	0.00228	CcSEcCtD
Aripiprazole—Hypokalaemia—Varenicline—nicotine dependence	0.00061	0.00227	CcSEcCtD
Aripiprazole—Breast disorder—Varenicline—nicotine dependence	0.000605	0.00226	CcSEcCtD
Aripiprazole—Cramp muscle—Varenicline—nicotine dependence	0.000603	0.00225	CcSEcCtD
Aripiprazole—Nasopharyngitis—Varenicline—nicotine dependence	0.000599	0.00223	CcSEcCtD
Aripiprazole—Gastritis—Varenicline—nicotine dependence	0.000593	0.00221	CcSEcCtD
Aripiprazole—Abdominal distension—Varenicline—nicotine dependence	0.000583	0.00217	CcSEcCtD
Aripiprazole—CHRM3—brain—nicotine dependence	0.000582	0.0111	CbGeAlD
Aripiprazole—HTR1A—brain—nicotine dependence	0.00058	0.011	CbGeAlD
Aripiprazole—Dysphagia—Varenicline—nicotine dependence	0.000579	0.00216	CcSEcCtD
Aripiprazole—Asthma—Varenicline—nicotine dependence	0.000579	0.00216	CcSEcCtD
Aripiprazole—Angina pectoris—Varenicline—nicotine dependence	0.000564	0.0021	CcSEcCtD
Aripiprazole—Abdominal discomfort—Varenicline—nicotine dependence	0.000555	0.00207	CcSEcCtD
Aripiprazole—HTR7—brain—nicotine dependence	0.000554	0.0105	CbGeAlD
Aripiprazole—HTR2A—midbrain—nicotine dependence	0.00055	0.0104	CbGeAlD
Aripiprazole—Perphenazine—DRD2—nicotine dependence	0.000541	0.103	CrCbGaD
Aripiprazole—Pollakiuria—Varenicline—nicotine dependence	0.000535	0.00199	CcSEcCtD
Aripiprazole—ADRA1A—brain—nicotine dependence	0.000535	0.0102	CbGeAlD
Aripiprazole—Erectile dysfunction—Varenicline—nicotine dependence	0.000533	0.00199	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Varenicline—nicotine dependence	0.000529	0.00197	CcSEcCtD
Aripiprazole—Weight increased—Varenicline—nicotine dependence	0.000527	0.00196	CcSEcCtD
Aripiprazole—DRD2—brain—nicotine dependence	0.000524	0.00995	CbGeAlD
Aripiprazole—Hyperglycaemia—Varenicline—nicotine dependence	0.000522	0.00195	CcSEcCtD
Aripiprazole—KCNH2—brain—nicotine dependence	0.000516	0.0098	CbGeAlD
Aripiprazole—Infestation—Varenicline—nicotine dependence	0.000516	0.00192	CcSEcCtD
Aripiprazole—Infestation NOS—Varenicline—nicotine dependence	0.000516	0.00192	CcSEcCtD
Aripiprazole—Depression—Varenicline—nicotine dependence	0.000515	0.00192	CcSEcCtD
Aripiprazole—ADRA2C—brain—nicotine dependence	0.000509	0.00967	CbGeAlD
Aripiprazole—Acute coronary syndrome—Varenicline—nicotine dependence	0.000509	0.0019	CcSEcCtD
Aripiprazole—Myocardial infarction—Varenicline—nicotine dependence	0.000506	0.00189	CcSEcCtD
Aripiprazole—Stomatitis—Varenicline—nicotine dependence	0.000503	0.00187	CcSEcCtD
Aripiprazole—Conjunctivitis—Varenicline—nicotine dependence	0.000502	0.00187	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Varenicline—nicotine dependence	0.000488	0.00182	CcSEcCtD
Aripiprazole—Epistaxis—Varenicline—nicotine dependence	0.000487	0.00181	CcSEcCtD
Aripiprazole—Sinusitis—Varenicline—nicotine dependence	0.000484	0.0018	CcSEcCtD
Aripiprazole—Bradycardia—Varenicline—nicotine dependence	0.000472	0.00176	CcSEcCtD
Aripiprazole—ABCB1—cardiovascular system—nicotine dependence	0.000462	0.00876	CbGeAlD
Aripiprazole—Hallucination—Varenicline—nicotine dependence	0.000461	0.00172	CcSEcCtD
Aripiprazole—Hypoaesthesia—Varenicline—nicotine dependence	0.000461	0.00172	CcSEcCtD
Aripiprazole—Urinary tract disorder—Varenicline—nicotine dependence	0.000458	0.00171	CcSEcCtD
Aripiprazole—Oedema peripheral—Varenicline—nicotine dependence	0.000457	0.0017	CcSEcCtD
Aripiprazole—Connective tissue disorder—Varenicline—nicotine dependence	0.000455	0.0017	CcSEcCtD
Aripiprazole—Urethral disorder—Varenicline—nicotine dependence	0.000454	0.00169	CcSEcCtD
Aripiprazole—Visual impairment—Varenicline—nicotine dependence	0.000447	0.00166	CcSEcCtD
Aripiprazole—Eye disorder—Varenicline—nicotine dependence	0.000433	0.00161	CcSEcCtD
Aripiprazole—Tinnitus—Varenicline—nicotine dependence	0.000432	0.00161	CcSEcCtD
Aripiprazole—Cardiac disorder—Varenicline—nicotine dependence	0.00043	0.0016	CcSEcCtD
Aripiprazole—Angiopathy—Varenicline—nicotine dependence	0.000421	0.00157	CcSEcCtD
Aripiprazole—Immune system disorder—Varenicline—nicotine dependence	0.000419	0.00156	CcSEcCtD
Aripiprazole—Mediastinal disorder—Varenicline—nicotine dependence	0.000418	0.00156	CcSEcCtD
Aripiprazole—Chills—Varenicline—nicotine dependence	0.000416	0.00155	CcSEcCtD
Aripiprazole—HRH1—brain—nicotine dependence	0.000414	0.00786	CbGeAlD
Aripiprazole—ADRA2A—brain—nicotine dependence	0.000407	0.00772	CbGeAlD
Aripiprazole—Mental disorder—Varenicline—nicotine dependence	0.000406	0.00151	CcSEcCtD
Aripiprazole—Erythema—Varenicline—nicotine dependence	0.000403	0.0015	CcSEcCtD
Aripiprazole—Malnutrition—Varenicline—nicotine dependence	0.000403	0.0015	CcSEcCtD
Aripiprazole—Flatulence—Varenicline—nicotine dependence	0.000398	0.00148	CcSEcCtD
Aripiprazole—Dysgeusia—Varenicline—nicotine dependence	0.000395	0.00147	CcSEcCtD
Aripiprazole—Back pain—Varenicline—nicotine dependence	0.00039	0.00145	CcSEcCtD
Aripiprazole—Muscle spasms—Varenicline—nicotine dependence	0.000388	0.00145	CcSEcCtD
Aripiprazole—Vision blurred—Varenicline—nicotine dependence	0.00038	0.00142	CcSEcCtD
Aripiprazole—Tremor—Varenicline—nicotine dependence	0.000378	0.00141	CcSEcCtD
Aripiprazole—Ill-defined disorder—Varenicline—nicotine dependence	0.000374	0.00139	CcSEcCtD
Aripiprazole—Anaemia—Varenicline—nicotine dependence	0.000373	0.00139	CcSEcCtD
Aripiprazole—Agitation—Varenicline—nicotine dependence	0.000371	0.00138	CcSEcCtD
Aripiprazole—Angioedema—Varenicline—nicotine dependence	0.000369	0.00137	CcSEcCtD
Aripiprazole—Malaise—Varenicline—nicotine dependence	0.000364	0.00136	CcSEcCtD
Aripiprazole—Vertigo—Varenicline—nicotine dependence	0.000363	0.00135	CcSEcCtD
Aripiprazole—Syncope—Varenicline—nicotine dependence	0.000362	0.00135	CcSEcCtD
Aripiprazole—ABCB1—midbrain—nicotine dependence	0.00036	0.00684	CbGeAlD
Aripiprazole—Palpitations—Varenicline—nicotine dependence	0.000357	0.00133	CcSEcCtD
Aripiprazole—Loss of consciousness—Varenicline—nicotine dependence	0.000355	0.00132	CcSEcCtD
Aripiprazole—Cough—Varenicline—nicotine dependence	0.000352	0.00131	CcSEcCtD
Aripiprazole—Convulsion—Varenicline—nicotine dependence	0.00035	0.0013	CcSEcCtD
Aripiprazole—Hypertension—Varenicline—nicotine dependence	0.000348	0.0013	CcSEcCtD
Aripiprazole—HTR2A—brain—nicotine dependence	0.000346	0.00656	CbGeAlD
Aripiprazole—Myalgia—Varenicline—nicotine dependence	0.000344	0.00128	CcSEcCtD
Aripiprazole—Arthralgia—Varenicline—nicotine dependence	0.000344	0.00128	CcSEcCtD
Aripiprazole—Chest pain—Varenicline—nicotine dependence	0.000344	0.00128	CcSEcCtD
Aripiprazole—Anxiety—Varenicline—nicotine dependence	0.000342	0.00128	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000341	0.00127	CcSEcCtD
Aripiprazole—Discomfort—Varenicline—nicotine dependence	0.000339	0.00126	CcSEcCtD
Aripiprazole—Dry mouth—Varenicline—nicotine dependence	0.000336	0.00125	CcSEcCtD
Aripiprazole—Oedema—Varenicline—nicotine dependence	0.000329	0.00123	CcSEcCtD
Aripiprazole—Infection—Varenicline—nicotine dependence	0.000327	0.00122	CcSEcCtD
Aripiprazole—Shock—Varenicline—nicotine dependence	0.000324	0.00121	CcSEcCtD
Aripiprazole—Nervous system disorder—Varenicline—nicotine dependence	0.000323	0.0012	CcSEcCtD
Aripiprazole—Thrombocytopenia—Varenicline—nicotine dependence	0.000322	0.0012	CcSEcCtD
Aripiprazole—Tachycardia—Varenicline—nicotine dependence	0.000321	0.0012	CcSEcCtD
Aripiprazole—Skin disorder—Varenicline—nicotine dependence	0.00032	0.00119	CcSEcCtD
Aripiprazole—Hyperhidrosis—Varenicline—nicotine dependence	0.000318	0.00119	CcSEcCtD
Aripiprazole—CYP2D6—brain—nicotine dependence	0.000315	0.00598	CbGeAlD
Aripiprazole—Anorexia—Varenicline—nicotine dependence	0.000314	0.00117	CcSEcCtD
Aripiprazole—Hypotension—Varenicline—nicotine dependence	0.000308	0.00115	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0003	0.00112	CcSEcCtD
Aripiprazole—Insomnia—Varenicline—nicotine dependence	0.000298	0.00111	CcSEcCtD
Aripiprazole—Dyspnoea—Varenicline—nicotine dependence	0.000294	0.00109	CcSEcCtD
Aripiprazole—Somnolence—Varenicline—nicotine dependence	0.000293	0.00109	CcSEcCtD
Aripiprazole—Dyspepsia—Varenicline—nicotine dependence	0.00029	0.00108	CcSEcCtD
Aripiprazole—Decreased appetite—Varenicline—nicotine dependence	0.000286	0.00107	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000284	0.00106	CcSEcCtD
Aripiprazole—Fatigue—Varenicline—nicotine dependence	0.000284	0.00106	CcSEcCtD
Aripiprazole—Pain—Varenicline—nicotine dependence	0.000282	0.00105	CcSEcCtD
Aripiprazole—Constipation—Varenicline—nicotine dependence	0.000282	0.00105	CcSEcCtD
Aripiprazole—Feeling abnormal—Varenicline—nicotine dependence	0.000271	0.00101	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Varenicline—nicotine dependence	0.000269	0.001	CcSEcCtD
Aripiprazole—Urticaria—Varenicline—nicotine dependence	0.000262	0.000975	CcSEcCtD
Aripiprazole—Body temperature increased—Varenicline—nicotine dependence	0.00026	0.00097	CcSEcCtD
Aripiprazole—Abdominal pain—Varenicline—nicotine dependence	0.00026	0.00097	CcSEcCtD
Aripiprazole—Hypersensitivity—Varenicline—nicotine dependence	0.000243	0.000904	CcSEcCtD
Aripiprazole—Asthenia—Varenicline—nicotine dependence	0.000236	0.00088	CcSEcCtD
Aripiprazole—Pruritus—Varenicline—nicotine dependence	0.000233	0.000868	CcSEcCtD
Aripiprazole—ABCB1—brain—nicotine dependence	0.000227	0.0043	CbGeAlD
Aripiprazole—Diarrhoea—Varenicline—nicotine dependence	0.000225	0.000839	CcSEcCtD
Aripiprazole—Dizziness—Varenicline—nicotine dependence	0.000218	0.000811	CcSEcCtD
Aripiprazole—Vomiting—Varenicline—nicotine dependence	0.000209	0.00078	CcSEcCtD
Aripiprazole—Rash—Varenicline—nicotine dependence	0.000208	0.000773	CcSEcCtD
Aripiprazole—Dermatitis—Varenicline—nicotine dependence	0.000207	0.000773	CcSEcCtD
Aripiprazole—Headache—Varenicline—nicotine dependence	0.000206	0.000768	CcSEcCtD
Aripiprazole—Nausea—Varenicline—nicotine dependence	0.000196	0.000729	CcSEcCtD
Aripiprazole—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	5.85e-05	0.000391	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	5.85e-05	0.000391	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	5.84e-05	0.00039	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	5.81e-05	0.000388	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—WASF1—nicotine dependence	5.78e-05	0.000386	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	5.76e-05	0.000385	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	5.71e-05	0.000381	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—FGD1—nicotine dependence	5.7e-05	0.000381	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	5.68e-05	0.00038	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	5.68e-05	0.000379	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—DRD2—nicotine dependence	5.64e-05	0.000377	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	5.63e-05	0.000376	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—FGD1—nicotine dependence	5.63e-05	0.000376	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	5.59e-05	0.000373	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	5.59e-05	0.000373	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	5.52e-05	0.000368	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	5.5e-05	0.000367	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	5.49e-05	0.000366	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	5.44e-05	0.000363	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	5.43e-05	0.000362	CbGpPWpGaD
Aripiprazole—HRH1—GPCR ligand binding—DRD2—nicotine dependence	5.41e-05	0.000362	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	5.4e-05	0.00036	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	5.4e-05	0.00036	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	5.39e-05	0.00036	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	5.38e-05	0.000359	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	5.37e-05	0.000358	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	5.35e-05	0.000357	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	5.34e-05	0.000357	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—WASF2—nicotine dependence	5.34e-05	0.000357	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	5.33e-05	0.000356	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	5.31e-05	0.000355	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	5.3e-05	0.000354	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	5.28e-05	0.000353	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	5.28e-05	0.000353	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	5.21e-05	0.000348	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	5.18e-05	0.000346	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	5.13e-05	0.000343	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—FGD1—nicotine dependence	5.13e-05	0.000342	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—WASF1—nicotine dependence	5.12e-05	0.000342	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	5.12e-05	0.000342	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	5.09e-05	0.00034	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	5.08e-05	0.000339	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	5.04e-05	0.000336	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	4.97e-05	0.000332	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	4.94e-05	0.00033	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	4.91e-05	0.000328	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	4.91e-05	0.000328	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—FGD1—nicotine dependence	4.9e-05	0.000327	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	4.88e-05	0.000326	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—FGD1—nicotine dependence	4.88e-05	0.000326	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—CYP2A7—nicotine dependence	4.8e-05	0.00032	CbGpPWpGaD
Aripiprazole—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	4.8e-05	0.00032	CbGpPWpGaD
Aripiprazole—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	4.79e-05	0.00032	CbGpPWpGaD
Aripiprazole—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	4.76e-05	0.000318	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	4.75e-05	0.000317	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	4.74e-05	0.000317	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	4.68e-05	0.000312	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	4.67e-05	0.000312	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	4.66e-05	0.000311	CbGpPWpGaD
Aripiprazole—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	4.66e-05	0.000311	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—CYP2A7—nicotine dependence	4.66e-05	0.000311	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	4.62e-05	0.000308	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—OPRM1—nicotine dependence	4.61e-05	0.000308	CbGpPWpGaD
Aripiprazole—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	4.59e-05	0.000306	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	4.53e-05	0.000302	CbGpPWpGaD
Aripiprazole—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	4.52e-05	0.000302	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	4.49e-05	0.0003	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	4.46e-05	0.000298	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	4.44e-05	0.000296	CbGpPWpGaD
Aripiprazole—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	4.38e-05	0.000292	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—DRD2—nicotine dependence	4.35e-05	0.000291	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—DRD2—nicotine dependence	4.35e-05	0.00029	CbGpPWpGaD
Aripiprazole—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	4.33e-05	0.000289	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	4.33e-05	0.000289	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	4.32e-05	0.000289	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	4.31e-05	0.000288	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	4.31e-05	0.000288	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	4.31e-05	0.000288	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—FGD1—nicotine dependence	4.3e-05	0.000287	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	4.25e-05	0.000283	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	4.24e-05	0.000283	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—FGD1—nicotine dependence	4.24e-05	0.000283	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	4.23e-05	0.000283	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	4.23e-05	0.000283	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—FGD1—nicotine dependence	4.23e-05	0.000282	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	4.22e-05	0.000282	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—FGD1—nicotine dependence	4.21e-05	0.000281	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	4.21e-05	0.000281	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—FGD1—nicotine dependence	4.2e-05	0.00028	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	4.19e-05	0.00028	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	4.16e-05	0.000278	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—DRD2—nicotine dependence	4.16e-05	0.000278	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—FGD1—nicotine dependence	4.16e-05	0.000278	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	4.15e-05	0.000277	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	4.15e-05	0.000277	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	4.13e-05	0.000276	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	4.12e-05	0.000275	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—CYP2A7—nicotine dependence	4.12e-05	0.000275	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—WASF2—nicotine dependence	4.12e-05	0.000275	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—WASF2—nicotine dependence	4.12e-05	0.000275	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	4.11e-05	0.000274	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—WASF2—nicotine dependence	4.09e-05	0.000273	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	4.07e-05	0.000272	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—WASF2—nicotine dependence	4.01e-05	0.000267	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	3.97e-05	0.000265	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—WASF1—nicotine dependence	3.95e-05	0.000264	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—WASF1—nicotine dependence	3.95e-05	0.000264	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—WASF2—nicotine dependence	3.94e-05	0.000263	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	3.93e-05	0.000263	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—WASF1—nicotine dependence	3.92e-05	0.000262	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	3.91e-05	0.000261	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—WASF2—nicotine dependence	3.89e-05	0.00026	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	3.86e-05	0.000258	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	3.85e-05	0.000257	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	3.85e-05	0.000257	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	3.84e-05	0.000257	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—WASF1—nicotine dependence	3.84e-05	0.000256	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	3.83e-05	0.000256	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	3.82e-05	0.000255	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	3.8e-05	0.000254	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—CYP2A7—nicotine dependence	3.78e-05	0.000253	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	3.78e-05	0.000252	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—WASF1—nicotine dependence	3.78e-05	0.000252	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	3.77e-05	0.000252	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—DRD2—nicotine dependence	3.77e-05	0.000251	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—WASF2—nicotine dependence	3.76e-05	0.000251	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—DRD2—nicotine dependence	3.75e-05	0.00025	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	3.74e-05	0.00025	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	3.73e-05	0.000249	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—WASF1—nicotine dependence	3.73e-05	0.000249	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—WASF2—nicotine dependence	3.72e-05	0.000249	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	3.72e-05	0.000248	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	3.71e-05	0.000248	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	3.71e-05	0.000248	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—DRD2—nicotine dependence	3.7e-05	0.000247	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	3.68e-05	0.000246	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	3.67e-05	0.000245	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	3.66e-05	0.000245	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—WASF1—nicotine dependence	3.61e-05	0.000241	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—WASF1—nicotine dependence	3.57e-05	0.000238	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—OPRM1—nicotine dependence	3.56e-05	0.000238	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—OPRM1—nicotine dependence	3.55e-05	0.000237	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	3.55e-05	0.000237	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—WASF2—nicotine dependence	3.55e-05	0.000237	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	3.53e-05	0.000236	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	3.53e-05	0.000236	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	3.5e-05	0.000234	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—WASF2—nicotine dependence	3.5e-05	0.000234	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—CYP2A7—nicotine dependence	3.47e-05	0.000232	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	3.46e-05	0.000231	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	3.43e-05	0.000229	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	3.4e-05	0.000227	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—OPRM1—nicotine dependence	3.4e-05	0.000227	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—WASF1—nicotine dependence	3.4e-05	0.000227	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	3.38e-05	0.000226	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	3.37e-05	0.000225	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	3.36e-05	0.000224	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—WASF1—nicotine dependence	3.36e-05	0.000224	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	3.34e-05	0.000223	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—DRD2—nicotine dependence	3.33e-05	0.000223	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	3.25e-05	0.000217	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	3.22e-05	0.000215	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	3.21e-05	0.000215	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	3.21e-05	0.000214	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—WASF2—nicotine dependence	3.19e-05	0.000213	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	3.16e-05	0.000211	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	3.12e-05	0.000208	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	3.07e-05	0.000205	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	3.07e-05	0.000205	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—OPRM1—nicotine dependence	3.06e-05	0.000204	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	3.06e-05	0.000204	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—WASF1—nicotine dependence	3.06e-05	0.000204	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—WASF2—nicotine dependence	3.05e-05	0.000204	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	3.05e-05	0.000204	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	3.04e-05	0.000203	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—WASF2—nicotine dependence	3.04e-05	0.000203	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	3.03e-05	0.000202	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—OPRM1—nicotine dependence	3.02e-05	0.000202	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	3.01e-05	0.000201	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	3e-05	0.0002	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	2.95e-05	0.000197	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—WASF1—nicotine dependence	2.93e-05	0.000195	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—WASF1—nicotine dependence	2.91e-05	0.000194	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	2.91e-05	0.000194	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	2.83e-05	0.000189	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	2.79e-05	0.000186	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	2.79e-05	0.000186	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	2.78e-05	0.000186	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—DRD2—nicotine dependence	2.78e-05	0.000186	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	2.77e-05	0.000185	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	2.76e-05	0.000184	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	2.75e-05	0.000184	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	2.73e-05	0.000183	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	2.73e-05	0.000182	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	2.73e-05	0.000182	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—WASF2—nicotine dependence	2.68e-05	0.000179	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—WASF2—nicotine dependence	2.64e-05	0.000176	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	2.63e-05	0.000176	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—WASF2—nicotine dependence	2.63e-05	0.000176	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—WASF2—nicotine dependence	2.62e-05	0.000175	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	2.62e-05	0.000175	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CYP2A7—nicotine dependence	2.62e-05	0.000175	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—WASF2—nicotine dependence	2.61e-05	0.000174	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—WASF2—nicotine dependence	2.59e-05	0.000173	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	2.58e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DRD2—nicotine dependence	2.57e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DRD2—nicotine dependence	2.57e-05	0.000172	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—WASF1—nicotine dependence	2.57e-05	0.000171	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DRD2—nicotine dependence	2.55e-05	0.00017	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	2.55e-05	0.00017	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	2.53e-05	0.000169	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—WASF1—nicotine dependence	2.53e-05	0.000169	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—WASF1—nicotine dependence	2.52e-05	0.000168	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—WASF1—nicotine dependence	2.51e-05	0.000168	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	2.51e-05	0.000167	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—WASF1—nicotine dependence	2.51e-05	0.000167	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DRD2—nicotine dependence	2.5e-05	0.000167	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—WASF1—nicotine dependence	2.48e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	2.47e-05	0.000165	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CYP2A7—nicotine dependence	2.47e-05	0.000165	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—DRD2—nicotine dependence	2.46e-05	0.000164	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DRD2—nicotine dependence	2.43e-05	0.000162	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	2.4e-05	0.00016	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DRD2—nicotine dependence	2.35e-05	0.000157	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DRD2—nicotine dependence	2.32e-05	0.000155	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.31e-05	0.000154	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	2.3e-05	0.000154	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	2.28e-05	0.000152	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—OPRM1—nicotine dependence	2.27e-05	0.000152	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	2.26e-05	0.000151	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	2.26e-05	0.000151	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	2.23e-05	0.000149	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	2.23e-05	0.000149	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DRD2—nicotine dependence	2.21e-05	0.000148	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—DRD2—nicotine dependence	2.18e-05	0.000146	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.07e-05	0.000138	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DRD2—nicotine dependence	1.99e-05	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	1.97e-05	0.000132	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DRD2—nicotine dependence	1.9e-05	0.000127	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DRD2—nicotine dependence	1.89e-05	0.000126	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	1.84e-05	0.000123	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	1.81e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD2—nicotine dependence	1.64e-05	0.00011	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD2—nicotine dependence	1.64e-05	0.00011	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD2—nicotine dependence	1.64e-05	0.000109	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD2—nicotine dependence	1.63e-05	0.000109	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD2—nicotine dependence	1.62e-05	0.000108	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.61e-05	0.000108	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	1.61e-05	0.000108	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	1.5e-05	9.99e-05	CbGpPWpGaD
